Skip to main content
. 2017 Nov 18;8(64):107477–107491. doi: 10.18632/oncotarget.22491

Figure 8. Immunohistochemistry of ILF3, CDH11 and HOXC8 in breast cancer specimens and analyses of ILF3, CDH11 and HOXC8 expression using publicly available datasets.

Figure 8

(A) IHC staining of CDH11, ILF3 and HOXC8 in normal breast and breast cancer tissues. Magnification, 200×; Scale bar, 200 μm. (B) mRNA expression levels of CDH11, ILF3 and HOXC8 in breast cancer specimens from different disease stages using the breast cancer dataset (Breast invasive carcinoma, TCGA, Nature 2012, 825 samples) from cBioPortal (www.cbioportal.org). (C) Kaplan-Meier survival plots show distant metastasis-free survival for breast cancer patients with high and low expression of CDH11, ILF3 or HOXC8. Data were analyzed using an online survival analysis tool (www.kmplot.com, probe ID: 217804_s_at for ILF3, 207173_x_at for CDH11 and 221350_at for HOXC8).